143 related articles for article (PubMed ID: 2068892)
21. Growth hormone-binding protein-related immunoreactivity in the serum of patients with acromegaly is regulated inversely by growth hormone concentration.
Kratzsch J; Blum WF; Ventz M; Selisko T; Birkenmeyer G; Keller E
Eur J Endocrinol; 1995 Mar; 132(3):306-12. PubMed ID: 7534176
[TBL] [Abstract][Full Text] [Related]
22. Development of a simple valid method for the complete removal of insulin-like growth factor (IGF)-binding proteins from IGFs in human serum and other biological fluids: comparison with acid-ethanol treatment and C18 Sep-Pak separation.
Mohan S; Baylink DJ
J Clin Endocrinol Metab; 1995 Feb; 80(2):637-47. PubMed ID: 7531716
[TBL] [Abstract][Full Text] [Related]
23. The effect of epidermal growth factor on circulating levels of free and total IGF-I and IGF-binding proteins in adult rats.
Frystyk J; Vinter-Jensen L; Skjaerbaek C; Flyvbjerg A
Growth Regul; 1996 Mar; 6(1):48-54. PubMed ID: 8717450
[TBL] [Abstract][Full Text] [Related]
24. Size heterogeneity of circulating growth hormone in acromegaly. "Big-big" GH forms are associated with inappropriately low IGF-I levels.
Arosio M; Nissim M; Ballabio M; Orefice R; Bazzoni N; Faglia G
Acta Endocrinol (Copenh); 1991 Aug; 125(2):150-9. PubMed ID: 1897332
[TBL] [Abstract][Full Text] [Related]
25. Diagnostic value of the acid-labile subunit in acromegaly: evaluation in comparison with insulin-like growth factor (IGF) I, and IGF-binding protein-1, -2, and -3.
Arosio M; Garrone S; Bruzzi P; Faglia G; Minuto F; Barreca A
J Clin Endocrinol Metab; 2001 Mar; 86(3):1091-8. PubMed ID: 11238491
[TBL] [Abstract][Full Text] [Related]
26. Serum insulin-like growth factor-binding protein-3 levels in the diagnosis of acromegaly.
Grinspoon S; Clemmons D; Swearingen B; Klibanski A
J Clin Endocrinol Metab; 1995 Mar; 80(3):927-32. PubMed ID: 7533774
[TBL] [Abstract][Full Text] [Related]
27. Production of recombinant insulin-like growth factor-II in the development of a radioimmunoassay in rainbow trout (Oncorhynchus mykiss).
Gentil V; Martin P; Smal J; Le Bail PY
Gen Comp Endocrinol; 1996 Nov; 104(2):156-67. PubMed ID: 8930606
[TBL] [Abstract][Full Text] [Related]
28. Characterization of the affinities of insulin-like growth factor (IGF)-binding proteins 1-4 for IGF-I, IGF-II, IGF-I/insulin hybrid, and IGF-I analogs.
Oh Y; Müller HL; Lee DY; Fielder PJ; Rosenfeld RG
Endocrinology; 1993 Mar; 132(3):1337-44. PubMed ID: 7679979
[TBL] [Abstract][Full Text] [Related]
29. Usefulness of different biochemical markers of the insulin-like growth factor (IGF) family in diagnosing growth hormone excess and deficiency in adults.
Marzullo P; Di Somma C; Pratt KL; Khosravi J; Diamandis A; Lombardi G; Colao A; Rosenfeld RG
J Clin Endocrinol Metab; 2001 Jul; 86(7):3001-8. PubMed ID: 11443159
[TBL] [Abstract][Full Text] [Related]
30. Diagnostic value of serum IGF-I and IGFBP-3 in growth hormone disorders in adults.
Kim HJ; Kwon SH; Kim SW; Park DJ; Shin CS; Park KS; Kim SY; Cho BY; Lee HK
Horm Res; 2001; 56(3-4):117-23. PubMed ID: 11847474
[TBL] [Abstract][Full Text] [Related]
31. Radioimmunoassay for insulin-like growth factor (IGF) II: interference by pure IGF-binding proteins.
Baxter RC
J Immunoassay; 1990; 11(4):445-58. PubMed ID: 1704386
[TBL] [Abstract][Full Text] [Related]
32. The insulin-like growth factor system in the circulation of patients with viral infections.
Baricević I; Nedić O; Nikolić JA; Nedeljković J
Clin Chem Lab Med; 2004; 42(10):1127-31. PubMed ID: 15552271
[TBL] [Abstract][Full Text] [Related]
33. Measurement of insulin-like growth factor-II in human plasma using a specific monoclonal antibody-based two-site immunoradiometric assay.
Crosby SR; Anderton CD; Westwood M; Holly JM; Cwyfan Hughes SC; Gibson M; Morrison CA; Young RJ; White A
J Endocrinol; 1993 Apr; 137(1):141-50. PubMed ID: 8492071
[TBL] [Abstract][Full Text] [Related]
34. Administration of growth hormone (GH), but not insulin-like growth factor-I (IGF-I), by continuous infusion can induce the formation of the 150-kilodalton IGF-binding protein-3 complex in GH-deficient rats.
Gargosky SE; Tapanainen P; Rosenfeld RG
Endocrinology; 1994 May; 134(5):2267-76. PubMed ID: 7512499
[TBL] [Abstract][Full Text] [Related]
35. Molecular forms of serum insulin-like growth factor (IGF)-binding proteins in man: relationships with growth hormone and IGFs and physiological significance.
Hardouin S; Gourmelen M; Noguiez P; Seurin D; Roghani M; Le Bouc Y; Povoa G; Merimee TJ; Hossenlopp P; Binoux M
J Clin Endocrinol Metab; 1989 Dec; 69(6):1291-301. PubMed ID: 2555386
[TBL] [Abstract][Full Text] [Related]
36. Determination of insulin-like growth factor-I in normal subjects and in patients with growth hormone disorders by radioimmunoassay using biosynthetic homologous peptide.
Inoue T; Watanabe N; Saito S; Yamasaki M; Saito H; Shirakawa N
Endocrinol Jpn; 1986 Dec; 33(6):919-27. PubMed ID: 3582270
[TBL] [Abstract][Full Text] [Related]
37. Insulin-like growth factor binding proteins (IGFBPs) in acromegaly.
Coulson VJ; Wass JA; Abdulla AF; Cotterill AM; Holly JM
Growth Regul; 1991 Sep; 1(3):119-24. PubMed ID: 1726836
[TBL] [Abstract][Full Text] [Related]
38. Comparison of extraction methods and assay validation for salmon insulin-like growth factor-I using commercially available components.
Shimizu M; Swanson P; Fukada H; Hara A; Dickhoff WW
Gen Comp Endocrinol; 2000 Jul; 119(1):26-36. PubMed ID: 10882546
[TBL] [Abstract][Full Text] [Related]
39. A novel method for the extraction of sheep insulin-like growth factors-I and -II from plasma prior to radioimmunoassay.
Moore LG; Mylek ME
J Endocrinol; 1993 May; 137(2):239-45. PubMed ID: 7686957
[TBL] [Abstract][Full Text] [Related]
40. Altered relation between circulating levels of insulin-like growth factor-binding protein-1 and insulin in growth hormone-deficient patients and insulin-dependent diabetic patients compared to that in healthy subjects.
Hilding A; Brismar K; Degerblad M; Thorén M; Hall K
J Clin Endocrinol Metab; 1995 Sep; 80(9):2646-52. PubMed ID: 7545695
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
